Neuphoria Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2026
Total Assets: $28.7M
Liabilities Breakdown FY2026
Total Liabilities: $4.1M
Asset Breakdown
Total Assets: $28.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.9M | 69.2% |
| Accounts Receivable | $813.4K | 2.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $3.5M | 12.2% |
| Intangible Assets | $4.1M | 14.4% |
| Other Assets | $389.8K | 1.4% |
Liabilities Breakdown
Total Liabilities: $4.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $385.6K | 9.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.7M | 90.6% |